BONANNI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 8.075
EU - Europa 7.722
AS - Asia 4.347
SA - Sud America 378
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 12
Totale 20.582
Nazione #
US - Stati Uniti d'America 8.029
IT - Italia 2.035
SG - Singapore 1.668
CN - Cina 1.393
IE - Irlanda 1.337
UA - Ucraina 1.136
TR - Turchia 782
SE - Svezia 747
GB - Regno Unito 702
FR - Francia 509
DE - Germania 494
BR - Brasile 326
IN - India 295
FI - Finlandia 269
RU - Federazione Russa 223
HK - Hong Kong 57
NL - Olanda 50
AT - Austria 42
CZ - Repubblica Ceca 40
VN - Vietnam 37
CA - Canada 33
BE - Belgio 26
IR - Iran 26
JP - Giappone 26
LU - Lussemburgo 25
EU - Europa 19
AR - Argentina 14
RO - Romania 14
CL - Cile 13
ES - Italia 11
MX - Messico 11
PL - Polonia 11
IQ - Iraq 10
BD - Bangladesh 9
PK - Pakistan 9
CH - Svizzera 8
DK - Danimarca 8
IL - Israele 7
NZ - Nuova Zelanda 7
PE - Perù 7
EC - Ecuador 6
EG - Egitto 6
MA - Marocco 6
NO - Norvegia 6
VE - Venezuela 6
AU - Australia 5
LT - Lituania 5
PT - Portogallo 5
AZ - Azerbaigian 4
HU - Ungheria 4
TN - Tunisia 4
BG - Bulgaria 3
GR - Grecia 3
JO - Giordania 3
KR - Corea 3
SC - Seychelles 3
SM - San Marino 3
TW - Taiwan 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
DZ - Algeria 1
GH - Ghana 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.582
Città #
Chandler 1.491
Jacksonville 1.342
Dublin 1.317
Singapore 1.147
Princeton 621
Southend 570
Izmir 418
Ashburn 407
Nanjing 407
Dearborn 290
Wilmington 272
The Dalles 238
Santa Clara 225
Cambridge 210
Chieti 200
Beijing 198
Altamura 195
Ann Arbor 144
Nanchang 139
Boardman 110
Pescara 109
Rome 100
Los Angeles 80
Milan 79
New York 79
Woodbridge 75
Helsinki 71
Hebei 69
Tianjin 68
Washington 66
Shenyang 61
Munich 58
Kunming 57
Hong Kong 56
Grevenbroich 49
Jiaxing 44
Norwalk 44
Changsha 41
Jinan 35
Dong Ket 34
Nuremberg 33
Hangzhou 32
Brno 30
Houston 30
Seattle 30
Florence 27
Augusta 26
Capurso 26
London 25
Toronto 25
Falls Church 24
Brussels 23
Lanzhou 23
São Paulo 23
Leawood 22
Ardabil 21
Pune 21
Belo Horizonte 20
Changchun 19
Hefei 19
Vienna 19
Frankfurt am Main 18
Ningbo 17
San Mateo 17
Dudelange 16
Naples 16
Camerino 15
Castignano 15
Chicago 15
Romola 15
Shanghai 15
Taizhou 15
Torino 15
Zhengzhou 15
Guangzhou 14
Paris 14
Redwood City 13
L'aquila 12
Ufa 12
Catania 11
Cepagatti 11
Düsseldorf 11
Spoltore 11
Amsterdam 9
Edinburgh 9
Luxembourg 9
Teramo 9
Lanciano 8
Monmouth Junction 8
Moscow 8
Napoli 8
Palermo 8
Vasto 8
Verona 8
Bologna 7
Cagliari 7
Genova 7
Mexico City 7
Olomouc 7
Turin 7
Totale 12.181
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 402
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 277
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 241
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 222
Pre-trattamento antiematico per Test/terapia all'apomorfina 164
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 134
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 134
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 133
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 125
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 124
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 116
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 115
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 115
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 112
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 108
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 107
Progetto atrofia multisistemica: risultati preliminari. 106
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 104
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 103
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 103
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 102
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 101
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 100
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 100
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 100
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 100
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 99
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 98
Akinetic crisis in Dementia with Lewy Bodies 98
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 96
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 95
Bipallidal lesions induce delayed and progressive parkinsonism 95
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 94
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 94
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 94
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 94
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 93
Attention network in AD and DLB patients: a resting fMRI study. 93
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 92
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 92
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 91
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 91
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 91
Instabilità posturale nel Parkinson non farmaco-responder 90
Improving diagnostic accuracy of DLB: An MRI study 90
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 90
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 90
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 90
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 89
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 89
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 89
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 87
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 87
Autoscopic phenomena: case report and review of literature. 87
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 87
Paradoxical kinesia in parkinsonian patients surviving earthquake. 86
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 85
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 85
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 85
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 85
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 85
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 84
Pathological Gambling in PD is reduced by Amantadine 84
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 84
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 84
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 83
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 83
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 82
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 82
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 81
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 81
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 81
Uso della amantadina nel trattamento delle discinesie e fluttuazioni motorie in pazienti affetti da Morbo di Parkinson 81
Medio-dorsal thalamus and confabulations: Evidence from a clinical case and combined MRI/DTI study 81
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 81
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 81
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 80
P300 response in early DLB and AD patients shows different topographic distribution 80
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 80
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 80
Interictal Heart Rate Variability Analysis Reveals Lateralization of Cardiac Autonomic Control in Temporal Lobe Epilepsy 80
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 79
Atrofia Multisistemica: approccio diagnostico multidisciplinare 79
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 79
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms. 79
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 79
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 79
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 78
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias 78
What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons 78
Mitochondrial Involvement in Neurodegenerative Dementia 78
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 78
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 77
Valutazione mediante sistema di immagini virtuali VRRS 77
Somatoform disorders in Parkinson’s Disease and Dementia with Lewy Bodies evidence underlying psychotic traits. 77
Valutazione dei potenziali evocati visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 77
Dynamics of peripheral blood T cell receptor V beta repertoire in patients with relapsing-remitting multiple sclerosis. 77
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 77
Post traumatic stress disorder heralding the onset of semantic frontotemporal dementia 77
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer's Disease: Graph Theory Applied to Resting State EEG 77
Totale 9.937
Categoria #
all - tutte 95.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020343 0 0 0 0 0 0 0 0 0 0 315 28
2020/20211.751 268 23 276 61 110 324 44 53 132 207 154 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20254.074 303 919 827 146 155 236 254 286 468 348 132 0
Totale 21.500